INS and obesity due to melanocortin 4 receptor deficiency: Insulin therapy among patients with diabetes also varied significantly across BMI categories: 11.0% in underweight, 9.4% in healthy-weight, 12.3% in overweight and 20.4% in obesity (p<0.001).